ImmunityBio, Inc. (IBRX)
USD 2.84
(-4.38%)
USD 2.84
(-4.38%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.09 Billion USD | 34.26% |
| 2022 | 812.17 Million USD | 13.94% |
| 2021 | 712.82 Million USD | 109.73% |
| 2020 | 339.87 Million USD | 1414.31% |
| 2019 | 22.44 Million USD | -37.56% |
| 2018 | 35.94 Million USD | 13.76% |
| 2017 | 31.59 Million USD | 31.22% |
| 2016 | 24.07 Million USD | 121.84% |
| 2015 | 10.85 Million USD | 351.31% |
| 2014 | 2.4 Million USD | -51.88% |
| 2013 | 4.99 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.09 Billion USD | 0.12% |
| 2024 Q2 | 1.14 Billion USD | 4.58% |
| 2023 Q3 | 843.06 Million USD | -9.97% |
| 2023 FY | 1.09 Billion USD | 34.26% |
| 2023 Q1 | 875.11 Million USD | 7.75% |
| 2023 Q2 | 936.41 Million USD | 7.0% |
| 2023 Q4 | 1.09 Billion USD | 29.34% |
| 2022 Q2 | 739.69 Million USD | 1.73% |
| 2022 Q4 | 812.17 Million USD | 3.86% |
| 2022 Q3 | 782.02 Million USD | 5.72% |
| 2022 FY | 812.17 Million USD | 13.94% |
| 2022 Q1 | 727.14 Million USD | 2.01% |
| 2021 Q4 | 712.82 Million USD | 76.28% |
| 2021 FY | 712.82 Million USD | 109.73% |
| 2021 Q2 | 404.88 Million USD | 2.56% |
| 2021 Q3 | 404.36 Million USD | -0.13% |
| 2021 Q1 | 394.76 Million USD | 16.15% |
| 2020 Q2 | 26.51 Million USD | 8.53% |
| 2020 FY | 339.87 Million USD | 1414.31% |
| 2020 Q4 | 339.87 Million USD | 8.13% |
| 2020 Q3 | 314.31 Million USD | 1085.6% |
| 2020 Q1 | 24.42 Million USD | -89.21% |
| 2019 Q4 | 226.41 Million USD | 833.65% |
| 2019 Q3 | 24.25 Million USD | -0.72% |
| 2019 Q2 | 24.42 Million USD | -39.62% |
| 2019 Q1 | 40.45 Million USD | 12.54% |
| 2019 FY | 22.44 Million USD | -37.56% |
| 2018 FY | 35.94 Million USD | 13.76% |
| 2018 Q1 | 29.48 Million USD | -6.68% |
| 2018 Q3 | 39.55 Million USD | 32.73% |
| 2018 Q4 | 35.94 Million USD | -9.13% |
| 2018 Q2 | 29.8 Million USD | 1.08% |
| 2017 Q3 | 40.03 Million USD | -17.79% |
| 2017 Q1 | 25.3 Million USD | 5.1% |
| 2017 Q2 | 48.69 Million USD | 92.43% |
| 2017 Q4 | 31.59 Million USD | -21.08% |
| 2017 FY | 31.59 Million USD | 31.22% |
| 2016 Q4 | 24.07 Million USD | 11.89% |
| 2016 Q2 | 15.57 Million USD | 20.5% |
| 2016 Q3 | 21.52 Million USD | 38.14% |
| 2016 FY | 24.07 Million USD | 121.84% |
| 2016 Q1 | 12.92 Million USD | 19.11% |
| 2015 FY | 10.85 Million USD | 351.31% |
| 2015 Q1 | 3.05 Million USD | 27.03% |
| 2015 Q4 | 10.85 Million USD | 49.5% |
| 2015 Q2 | 6.03 Million USD | 97.68% |
| 2015 Q3 | 7.26 Million USD | 20.22% |
| 2014 FY | 2.4 Million USD | -51.88% |
| 2014 Q4 | 2.4 Million USD | 0.0% |
| 2013 FY | 4.99 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -224.737% |
| Alkermes plc | 933.53 Million USD | -16.802% |
| Agenus Inc. | 462.29 Million USD | -135.864% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 73.08% |
| Aptorum Group Limited | 5.25 Million USD | -20642.693% |
| Ardelyx, Inc. | 130.76 Million USD | -733.867% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -127.929% |
| Bicycle Therapeutics plc | 224.41 Million USD | -385.887% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -737.408% |
| ChromaDex Corporation | 26.5 Million USD | -4013.434% |
| Chimerix, Inc. | 19.74 Million USD | -5422.355% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -2999.711% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -1402.596% |
| CRISPR Therapeutics AG | 346.76 Million USD | -214.443% |
| Precision BioSciences, Inc. | 140.92 Million USD | -673.765% |
| Dyadic International, Inc. | 2.34 Million USD | -46484.86% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -6604.722% |
| Fortress Biotech, Inc. | 165.93 Million USD | -557.102% |
| Lantern Pharma Inc. | 2.73 Million USD | -39699.838% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -1425.446% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -30800.368% |
| Incyte Corporation | 1.59 Billion USD | 31.52% |
| IO Biotech, Inc. | 17.55 Million USD | -6110.919% |
| Jaguar Health, Inc. | 45.86 Million USD | -2277.336% |
| Novavax, Inc. | 2.57 Billion USD | 57.61% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -2923.986% |
| Opthea Limited | 264.6 Million USD | -312.088% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -734.224% |
| ContextLogic Inc. | 206 Million USD | -429.315% |
| MiMedx Group, Inc. | 96.33 Million USD | -1031.931% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -2170.603% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -30798.949% |
| NextCure, Inc. | 14.99 Million USD | -7170.714% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -26876.472% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -16230.523% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -2232.932% |
| Vaxcyte, Inc. | 167.44 Million USD | -551.177% |
| PDS Biotechnology Corporation | 33.25 Million USD | -3178.465% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -363.573% |
| Pharming Group N.V. | 244.07 Million USD | -346.747% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -9046.024% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -753.26% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -16402.845% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -16402.845% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -1222.758% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -16314.105% |
| Acelyrin, Inc. | 86.35 Million USD | -1162.711% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -83825.076% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -7483.205% |
| Summit Therapeutics Inc. | 125.25 Million USD | -770.521% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -11403.207% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1974.126% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -1485.398% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -619.672% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -55645.859% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -81542.587% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -380.703% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -11540.749% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -379.408% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -120.499% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -9890.737% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -3863.466% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -8907.981% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -124.083% |
| Immix Biopharma, Inc. | 3.72 Million USD | -29197.49% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -2783.712% |
| MEI Pharma, Inc. | 8.35 Million USD | -12950.736% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -3658.018% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -213.709% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -647.512% |
| Fortress Biotech, Inc. | 165.93 Million USD | -557.102% |
| Precigen, Inc. | 41.64 Million USD | -2518.358% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -2083.835% |
| AlloVir, Inc. | 45.01 Million USD | -2322.279% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -736.592% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -691.284% |
| ImmuCell Corporation | 18.81 Million USD | -5695.31% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -3763.066% |
| Onconetix, Inc. | 23.18 Million USD | -4603.828% |
| PureTech Health plc | 125.58 Million USD | -768.262% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -12083.117% |
| Elevation Oncology, Inc. | 34.28 Million USD | -3080.646% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -44496.687% |
| Seer, Inc. | 39.36 Million USD | -2669.945% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -1663.413% |
| Innoviva, Inc. | 568.55 Million USD | -91.784% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -3904.661% |
| ESSA Pharma Inc. | 3.49 Million USD | -31097.907% |
| GlycoMimetics, Inc. | 6.9 Million USD | -15697.991% |
| GT Biopharma, Inc. | 6.63 Million USD | -16338.851% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -312.417% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -300.456% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -1197.68% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -11056.016% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -3913.357% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -33702.41% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -1378.153% |
| Aptose Biosciences Inc. | 15.8 Million USD | -6797.398% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -9776.993% |
| Soligenix, Inc. | 7.27 Million USD | -14888.363% |
| Century Therapeutics, Inc. | 175.94 Million USD | -519.747% |
| Kura Oncology, Inc. | 51.66 Million USD | -2010.621% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -799.053% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -26282.507% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -16386.436% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -331.67% |
| Autolus Therapeutics plc | 263.9 Million USD | -313.172% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -10302.49% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -1127.073% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -2224.973% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -209.018% |
| GRI Bio, Inc. | 2.69 Million USD | -40329.7% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -134584.931% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -3407.089% |
| IGM Biosciences, Inc. | 220.17 Million USD | -395.233% |
| INmune Bio, Inc. | 18.86 Million USD | -5680.877% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -325.138% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -3992.773% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -40011.337% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -33140.871% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1765.348% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -1033.944% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -311.879% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -32.485% |
| Verastem, Inc. | 71.18 Million USD | -1431.768% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -2117.319% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -2726.453% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -2128.376% |
| Histogen Inc. | 5.69 Million USD | -19039.705% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -24762.909% |
| Surrozen, Inc. | 8.14 Million USD | -13287.219% |
| Organovo Holdings, Inc. | 2.74 Million USD | -39579.367% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -347314.754% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1839.162% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -6503.616% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -2033.708% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -131768.662% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -760.437% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -9983.506% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -622.643% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -41719.897% |
| Apollomics, Inc. | 14.15 Million USD | -7604.296% |
| Amarin Corporation plc | 279.58 Million USD | -290.0% |
| Mesoblast Limited | 188.79 Million USD | -477.543% |
| Turnstone Biologics Corp. | 14.14 Million USD | -7607.019% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -503.131% |
| Synaptogenix, Inc. | 5.52 Million USD | -19619.597% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -16301.76% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -540.998% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -12642.368% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -61945.826% |
| Exelixis, Inc. | 678.44 Million USD | -60.719% |
| Better Therapeutics, Inc. | 23.84 Million USD | -4473.396% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -564.685% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -83.503% |
| NLS Pharmaceutics AG | 10.68 Million USD | -10109.44% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -67058.06% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -2701.112% |
| Gritstone bio, Inc. | 125.91 Million USD | -765.945% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -7329.742% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -21327.961% |
| Avid Bioservices, Inc. | 275.66 Million USD | -295.544% |
| Insmed Incorporated | 1.66 Billion USD | 34.383% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -14071.895% |
| MediWound Ltd. | 27.18 Million USD | -3910.7% |
| OmniAb, Inc. | 87.4 Million USD | -1147.585% |
| Alector, Inc. | 487.66 Million USD | -123.592% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -170.262% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -5817.986% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -2741.553% |
| Zai Lab Limited | 240.17 Million USD | -353.994% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -73.062% |
| Aura Biosciences, Inc. | 29.22 Million USD | -3630.759% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -1046.848% |
| Immunic, Inc. | 25.36 Million USD | -4198.285% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -1474.887% |
| Veracyte, Inc. | 93.71 Million USD | -1063.466% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -41570.816% |
| FibroGen, Inc. | 585.72 Million USD | -86.16% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -6172.732% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -166862.038% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -19180.295% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 85.758% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -13200.671% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -1197.742% |
| TG Therapeutics, Inc. | 169.08 Million USD | -544.876% |
| Galecto, Inc. | 5.89 Million USD | -18393.708% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -13062.591% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 58.357% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -3683.183% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -8539.482% |
| XBiotech Inc. | 8.39 Million USD | -12885.459% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -7329.742% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1950.374% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -200.295% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -3955.903% |
| Theravance Biopharma, Inc. | 169 Million USD | -545.185% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 10.3% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -117.892% |
| Vaxxinity, Inc. | 30.94 Million USD | -3423.749% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -12.124% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -17979.417% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -46.315% |
| NexImmune, Inc. | 5.08 Million USD | -21346.484% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -293493.596% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -35361.558% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 84.658% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -21056.047% |
| Scopus BioPharma Inc. | 7.45 Million USD | -14527.388% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -4046.912% |
| Ainos, Inc. | 7.39 Million USD | -14646.499% |
| Pluri Inc. | 34.11 Million USD | -3096.497% |
| Prothena Corporation plc | 135.01 Million USD | -707.594% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -348.53% |
| Celularity Inc. | 102.92 Million USD | -959.36% |
| Rallybio Corporation | 9.43 Million USD | -11455.627% |
| Cue Biopharma, Inc. | 24.44 Million USD | -4360.581% |
| MeiraGTx Holdings plc | 319.99 Million USD | -240.756% |
| Omeros Corporation | 403.25 Million USD | -170.399% |
| Humacyte, Inc. | 114.67 Million USD | -850.835% |
| Immunocore Holdings plc | 228.15 Million USD | -377.91% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -22266.954% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -1320.887% |
| Blueprint Medicines Corporation | 918.64 Million USD | -18.696% |
| CalciMedica, Inc. | 4.02 Million USD | -26970.233% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -6147.931% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -607.388% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -1170.598% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -292.519% |
| Pulmatrix, Inc. | 15.96 Million USD | -6730.727% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -6813.01% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -4331.395% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -334.75% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -2047.026% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 9.933% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -3330.73% |
| Nutriband Inc. | 1.07 Million USD | -100963.101% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -10154.763% |
| Vor Biopharma Inc. | 59.1 Million USD | -1744.865% |
| Roivant Sciences Ltd. | 773.95 Million USD | -40.886% |
| Evogene Ltd. | 17.99 Million USD | -5961.084% |
| ProKidney Corp. | 29.21 Million USD | -3632.164% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -1414.871% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -154568.836% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 42.274% |
| CorMedix Inc. | 11.91 Million USD | -9049.456% |
| BioLineRx Ltd. | 50.7 Million USD | -2050.584% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -629.557% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -1132.9% |
| Atai Life Sciences N.V. | 49.16 Million USD | -2117.951% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -3400.187% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -5970.532% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -774.859% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -19185.267% |
| MediciNova, Inc. | 3.89 Million USD | -27919.379% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -5865.255% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -72387.653% |
| GeoVax Labs, Inc. | 3.51 Million USD | -30878.007% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -174.478% |
| Biomea Fusion, Inc. | 30.69 Million USD | -3452.913% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 59.938% |
| Mereo BioPharma Group plc | 15.96 Million USD | -6731.155% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -3394.725% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1758.069% |
| Absci Corporation | 58.3 Million USD | -1770.179% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -5624.428% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -3300.877% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -1377.692% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -1146.401% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -3128.869% |
| Allakos Inc. | 74.79 Million USD | -1357.876% |
| Imunon, Inc. | 8.53 Million USD | -12682.35% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -4745.958% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -849.717% |
| BioAtla, Inc. | 48.98 Million USD | -2125.92% |
| NLS Pharmaceutics AG | 10.68 Million USD | -10109.44% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -39136.74% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -734.882% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -7570.693% |
| XOMA Corporation | 145.58 Million USD | -648.996% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -3138.94% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -1485.813% |
| aTyr Pharma, Inc. | 31.59 Million USD | -3350.926% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -1663.727% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -2324.973% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -2152.777% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -37892.648% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -13265.857% |
| Akari Therapeutics, Plc | 4.58 Million USD | -23686.846% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -6048.881% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 33.894% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -269859.743% |
| UroGen Pharma Ltd. | 243.52 Million USD | -347.756% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -239.593% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -39384.559% |
| Orgenesis Inc. | 35.53 Million USD | -2968.493% |
| Entera Bio Ltd. | 1.37 Million USD | -78970.993% |
| GH Research PLC | 6.7 Million USD | -16172.034% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -15935.132% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -5691.931% |
| Xencor, Inc. | 283.55 Million USD | -284.537% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -36420.686% |
| Replimune Group, Inc. | 113.21 Million USD | -863.122% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -28921.898% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -953.211% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -269859.743% |
| Portage Biotech Inc. | 4.45 Million USD | -24403.124% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -72387.653% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -4630.538% |
| OncoCyte Corporation | 49.29 Million USD | -2111.832% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -26258.24% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -136628.637% |
| Purple Biotech Ltd. | 10 Million USD | -10798.441% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -18745.299% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1804.244% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -8701.963% |
| HilleVax, Inc. | 78.9 Million USD | -1281.831% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -21491.861% |
| Tharimmune, Inc. | 1.81 Million USD | -59975.006% |
| Genprex, Inc. | 3.25 Million USD | -33407.047% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -3920.757% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -20724.847% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -529215.049% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -304012.42% |
| OKYO Pharma Limited | 7.42 Million USD | -14593.594% |
| Savara Inc. | 37.19 Million USD | -2831.784% |
| Curis, Inc. | 57.61 Million USD | -1792.642% |
| Daré Bioscience, Inc. | 26.32 Million USD | -4041.265% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -2681.619% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -75411.704% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -5137.471% |
| BeiGene, Ltd. | 2.23 Billion USD | 51.186% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -5021.65% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -315.549% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -5025.454% |
| Erasca, Inc. | 78.61 Million USD | -1287.069% |
| bluebird bio, Inc. | 424.62 Million USD | -156.789% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -166307.581% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 42.309% |
| DBV Technologies S.A. | 42.8 Million USD | -2447.638% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -166307.581% |
| Moderna, Inc. | 4.57 Billion USD | 76.151% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -15488.12% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -65744.746% |
| Molecular Templates, Inc. | 31.17 Million USD | -3398.088% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -6287.75% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -85.408% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -775.779% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -3874.155% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -2890.973% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1859.898% |
| MacroGenics, Inc. | 154.2 Million USD | -607.094% |
| RenovoRx, Inc. | 4.46 Million USD | -24315.338% |
| Adicet Bio, Inc. | 37.12 Million USD | -2837.47% |
| Prime Medicine, Inc. | 60.78 Million USD | -1693.993% |
| Aditxt, Inc. | 28.53 Million USD | -3721.695% |
| Adagene Inc. | 45.16 Million USD | -2314.002% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -603321.674% |
| Quantum-Si incorporated | 26.63 Million USD | -3994.435% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -56.313% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -35739.317% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -848.486% |
| SciSparc Ltd. | 1.59 Million USD | -68262.947% |
| Vericel Corporation | 127.7 Million USD | -753.834% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -19494.066% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -1177.429% |
| Generation Bio Co. | 171.63 Million USD | -535.314% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -9340.597% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -2506.653% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -331.499% |
| Invivyd, Inc. | 51.71 Million USD | -2008.539% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -1085.502% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -16661.675% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -1344.3% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -106696.18% |
| 2seventy bio, Inc. | 310.12 Million USD | -251.595% |
| ADMA Biologics, Inc. | 193.97 Million USD | -462.126% |
| Clene Inc. | 38.95 Million USD | -2699.386% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -2917.721% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -324.316% |
| GeoVax Labs, Inc. | 3.51 Million USD | -30878.007% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -473.096% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -8852.539% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -449.807% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -8841.426% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -2166.403% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1963.528% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -194.816% |
| Evaxion Biotech A/S | 17.61 Million USD | -6089.245% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -577.559% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -611.807% |
| Trevena, Inc. | 48.26 Million USD | -2159.312% |
| Surrozen, Inc. | 8.14 Million USD | -13287.219% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -4949.266% |
| Cingulate Inc. | 10.36 Million USD | -10424.112% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -39550.509% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -2823.922% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -30302.424% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -8191.932% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -243.753% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -4288.06% |
| Clearmind Medicine Inc. | 3.61 Million USD | -30104.615% |
| Kronos Bio, Inc. | 54.2 Million USD | -1911.751% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -2217.856% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -4690.869% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -5332.659% |
| Statera Biopharma, Inc. | 22.67 Million USD | -4708.464% |
| Korro Bio, Inc. | 51.75 Million USD | -2006.95% |
| Kineta, Inc. | 7.22 Million USD | -14998.158% |
| BioVie Inc. | 9.7 Million USD | -11138.656% |
| Codexis, Inc. | 49.94 Million USD | -2083.136% |
| Celularity Inc. | 102.92 Million USD | -959.36% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -1032.907% |
| Celcuity Inc. | 51.45 Million USD | -2019.315% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -315777.159% |
| Cibus, Inc. | 206.11 Million USD | -429.015% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -2467.131% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -4039.827% |
| IN8bio, Inc. | 8.77 Million USD | -12330.335% |
| Kodiak Sciences Inc. | 213.59 Million USD | -410.503% |
| Annexon, Inc. | 47.11 Million USD | -2214.167% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -1117.754% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -1031.438% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -7865.439% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 58.117% |
| Eyenovia, Inc. | 19.78 Million USD | -5412.505% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -515.74% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -14095.925% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -4424.623% |
| Arcellx, Inc. | 339.75 Million USD | -220.937% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -9064.473% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -344.078% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -11302.165% |
| Moolec Science SA | 13.94 Million USD | -7719.012% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -2426.856% |
| Geron Corporation | 146.12 Million USD | -646.193% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -2057.819% |
| Royalty Pharma plc | 6.29 Billion USD | 82.686% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -2641.324% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -370269.15% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -44219.676% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -476.45% |
| Humacyte, Inc. | 114.67 Million USD | -850.835% |
| Structure Therapeutics Inc. | 29.05 Million USD | -3653.361% |
| 89bio, Inc. | 59.96 Million USD | -1718.436% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -4020.429% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -91069.649% |
| Genelux Corporation | 8.42 Million USD | -12849.988% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -15804.157% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -699.88% |
| Notable Labs, Ltd. | 4.42 Million USD | -24530.427% |
| Liquidia Corporation | 73.13 Million USD | -1390.865% |
| Mustang Bio, Inc. | 17.61 Million USD | -6088.711% |
| Immunovant, Inc. | 48.95 Million USD | -2127.329% |
| Quantum-Si incorporated | 26.63 Million USD | -3994.435% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -2740.812% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -35039.832% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -1376.272% |
| Acasti Pharma Inc. | 11.55 Million USD | -9334.879% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -4723.08% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -40011.337% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -2856.827% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -79908.468% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -17786.959% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -4290.534% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -4603.196% |
| PepGen Inc. | 34.63 Million USD | -3048.592% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -8878.829% |
| United Therapeutics Corporation | 1.18 Billion USD | 7.766% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -15512.672% |
| Solid Biosciences Inc. | 38.45 Million USD | -2735.272% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -12642.368% |
| Immuneering Corporation | 12 Million USD | -8980.253% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -347314.754% |
| Silo Pharma, Inc. | 1.56 Million USD | -69383.836% |
| Belite Bio, Inc | 4.21 Million USD | -25793.826% |
| XOMA Corporation | 145.58 Million USD | -648.996% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -44808.937% |
| Bionomics Limited | 10.15 Million USD | -10633.526% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -4973.701% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -4658.823% |
| uniQure N.V. | 624.01 Million USD | -74.737% |
| Cassava Sciences, Inc. | 14.19 Million USD | -7581.501% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -603321.674% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -540.712% |
| Forte Biosciences, Inc. | 3.66 Million USD | -29643.29% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -418342.109% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -16061.094% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -14095.925% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -6172.732% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -10217.837% |
| Altimmune, Inc. | 16.54 Million USD | -6492.038% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -76.522% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -4658.823% |
| Compugen Ltd. | 55.77 Million USD | -1854.978% |
| Peak Bio, Inc. | 20.75 Million USD | -5154.035% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -887.108% |
| Benitec Biopharma Inc. | 4.96 Million USD | -21874.788% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -590.806% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -1350.487% |
| Zura Bio Limited | 21.29 Million USD | -5021.121% |
| PolyPid Ltd. | 17.46 Million USD | -6142.209% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -870.106% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -1350.487% |
| Instil Bio, Inc. | 99.8 Million USD | -992.563% |
| argenx SE | 444.95 Million USD | -145.058% |
| Immunome, Inc. | 28.65 Million USD | -3704.833% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -12978.913% |
| Verona Pharma plc | 58.84 Million USD | -1753.111% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -7433.953% |
| Shattuck Labs, Inc. | 14.85 Million USD | -7238.239% |
| CervoMed Inc. | 2.59 Million USD | -41906.752% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -22271.543% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -8461.471% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -10250.157% |
| Moolec Science SA | 13.94 Million USD | -7719.012% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -46428.148% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1861.297% |
| AnaptysBio, Inc. | 364.28 Million USD | -199.322% |
| Design Therapeutics, Inc. | 11.95 Million USD | -9020.015% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -8496.57% |
| NeurAxis, Inc. | 1.91 Million USD | -56906.68% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -2701.04% |
| Lumos Pharma, Inc. | 13.33 Million USD | -8078.122% |
| Achilles Therapeutics plc | 19.08 Million USD | -5612.731% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -7433.953% |
| 180 Life Sciences Corp. | 5.38 Million USD | -20140.332% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -4522.645% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -4690.869% |
| Nutriband Inc. | 1.07 Million USD | -100963.101% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -3463.596% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -7414.224% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -171.732% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -3257.833% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -8256.05% |
| Palisade Bio, Inc. | 2.73 Million USD | -39709.748% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -20657.453% |
| Beam Therapeutics Inc. | 478.38 Million USD | -127.931% |
| Neurogene Inc. | 36.54 Million USD | -2883.362% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -174.001% |
| AEON Biopharma, Inc. | 159.88 Million USD | -581.966% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -2188.329% |
| Sesen Bio, Inc. | 30.98 Million USD | -3419.2% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -4100.104% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -14243.042% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -457.066% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -467.742% |
| Athira Pharma, Inc. | 30.05 Million USD | -3527.737% |
| Vaccinex, Inc. | 5.94 Million USD | -18250.539% |
| HCW Biologics Inc. | 15.05 Million USD | -7144.174% |
| XOMA Corporation | 145.58 Million USD | -648.996% |
| Nektar Therapeutics | 267.04 Million USD | -308.315% |
| Arvinas, Inc. | 644.6 Million USD | -69.157% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -6048.881% |
| Merus N.V. | 102.15 Million USD | -967.429% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -645.056% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -1046.33% |
| Rezolute, Inc. | 11.73 Million USD | -9192.56% |
| Clene Inc. | 38.95 Million USD | -2699.386% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -38194.467% |
| BeyondSpring Inc. | 48.26 Million USD | -2158.984% |
| Synlogic, Inc. | 32.89 Million USD | -3214.756% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -7361.774% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -66631.273% |
| Peak Bio, Inc. | 20.75 Million USD | -5154.035% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -1618.257% |
| Krystal Biotech, Inc. | 39.71 Million USD | -2645.604% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -189.501% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -995.109% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -251881.392% |
| MannKind Corporation | 721.36 Million USD | -51.156% |
| Ikena Oncology, Inc. | 22.33 Million USD | -4781.974% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -52171.764% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -962.861% |
| Gossamer Bio, Inc. | 249.14 Million USD | -337.649% |
| CohBar, Inc. | 1.03 Million USD | -105390.413% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -10101.038% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -5624.428% |
| Legend Biotech Corporation | 589.93 Million USD | -84.833% |
| Mural Oncology plc | 37.92 Million USD | -2774.892% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -722.091% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -47404.631% |
| Disc Medicine, Inc. | 22.87 Million USD | -4666.728% |
| Champions Oncology, Inc. | 28.03 Million USD | -3789.385% |
| REGENXBIO Inc. | 262.22 Million USD | -315.817% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -32358.313% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -8599.449% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -8018.071% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -5042.132% |
| Vaxart, Inc. | 34.02 Million USD | -3104.67% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -5247.859% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -3721.651% |
| Cellectis S.A. | 249.57 Million USD | -336.898% |
| Longeveron Inc. | 5.33 Million USD | -20330.748% |
| Repare Therapeutics Inc. | 41.81 Million USD | -2507.401% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 54.666% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1706.237% |
| Revolution Medicines, Inc. | 262.39 Million USD | -315.549% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -51650.783% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -12540.726% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -9139.802% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -7664.644% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -50592.19% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 78.827% |
| Denali Therapeutics Inc. | 122.96 Million USD | -786.762% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -19494.066% |
| Veru Inc. | 32.81 Million USD | -3223.069% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -15774.057% |
| Cingulate Inc. | 10.36 Million USD | -10424.112% |
| Passage Bio, Inc. | 39.26 Million USD | -2677.212% |
| Context Therapeutics Inc. | 4.19 Million USD | -25912.957% |
| Exicure, Inc. | 8.54 Million USD | -12654.579% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -3595.232% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -10298.522% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -4847.094% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -569.008% |
| Nuvalent, Inc. | 31.82 Million USD | -3326.418% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -17040.096% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -1630.172% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -5957.717% |
| OmniAb, Inc. | 87.4 Million USD | -1147.585% |
| Anew Medical, Inc. | 8.24 Million USD | -13129.988% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -2747.78% |
| Lipocine Inc. | 2.63 Million USD | -41333.994% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -4050.384% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -2611.601% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -3992.773% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -1165.628% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -20088.65% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -1217.738% |
| Ocugen, Inc. | 23.98 Million USD | -4446.508% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -2249.622% |
| Q32 Bio Inc. | 233.12 Million USD | -367.721% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -11927.234% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1938.034% |
| Equillium, Inc. | 27.95 Million USD | -3800.236% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -427.798% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -19278.957% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -17679.141% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -593.076% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -1470.419% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -10832.094% |
| Dominari Holdings Inc. | 4.63 Million USD | -23425.113% |
| Edesa Biotech, Inc. | 1.84 Million USD | -59107.596% |
| vTv Therapeutics Inc. | 29.56 Million USD | -3587.858% |
| Bio-Techne Corporation | 744.34 Million USD | -46.491% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -764.709% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -216.554% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -2587.342% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -3665.545% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -1080.586% |
| Nkarta, Inc. | 105.6 Million USD | -932.565% |
| BioCardia, Inc. | 4.59 Million USD | -23655.752% |
| Iterum Therapeutics plc | 32.66 Million USD | -3238.402% |